29. During development of RDU-90, Devlin MacGregor’s patent…
29. During development of RDU-90, Devlin MacGregor’s patent application covering the drug is approved by the USPTO. Shortly afterward, the FDA contacts Devlin MacGregor requesting additional information regarding laboratory results and safety testing before the company can market the drug. Nichols says to you, “Wait a minute, didn’t we secure the U.S. patent for the RDU-90 drug?” You answer, “Yes, I did.” Nichols replies, “So we already have permission from the government to sell it then.” Is Nichols correct?